Baystate cardiologist works with patients to improve lifestyles, heart health

Amir S. Lotfi, MD, a cardiologist at Baystate Health in Springfield, Massachusetts, has a unique approach to treating his patients, one that includes getting to know them, reports Mass Live.

Lotfi is the medical director for the inpatient heart and vascular program, and he focuses on building what he calls “partnerships” with patients to help them live healthier lives. He gets to know his patients beyond their medical information and advises them on dietary and exercise habits that can improve their overall health.

"You can't just say, Amir, you had a heart attack. Here are five pills, go home. That does not really address the bigger question,” Lotfi said.

To read more about Lotfi’s holistic approach to cardiology, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.